Companies / Sellas Life Sciences Group Inc / Activity
Activity — Sellas Life Sciences Group Inc
8 moves.
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | Stergiou Angelos M. CEO | Grant | Common Stock | $0 | +1.1M +153.42% | 1,759,183 0.87% of shares | low |
| Jan 7, 2026 | Kalin Katherine Bach Director | Grant | Common Stock | $0 | +50K +47.89% | 154,400 0.08% of shares | low |
| Jan 7, 2026 | Burns John Thomas Executive | Grant | Common Stock | $0 | +300K +117.96% | 554,327 0.27% of shares | low |
| Jan 7, 2026 | Cicic Dragan Executive | Grant | Common Stock | $0 | +300K +116.37% | 557,805 0.28% of shares | low |
| Jan 7, 2026 | Varian John Director | Grant | Common Stock | $0 | +50K +218.34% | 72,900 0.04% of shares | low |
| Jan 7, 2026 | Van Nostrand Robert L Director | Grant | Common Stock | $0 | +50K +151.98% | 82,900 0.04% of shares | low |
| Jan 7, 2026 | Scheinberg David a Director | Grant | Common Stock | $0 | +50K +216.62% | 73,082 0.04% of shares | low |
| Jan 7, 2026 | Wasman Jane Director | Grant | Common Stock | $0 | +50K +116.55% | 92,900 0.05% of shares | low |